Vanguard Group Inc I Teos Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $5.97 Trillion
  • Q2 2025

A detailed history of Vanguard Group Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,664,161 shares of ITOS stock, worth $16.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,664,161
Previous 1,726,458 3.61%
Holding current value
$16.8 Million
Previous $10.3 Million 60.98%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$5.04 - $10.2 $313,976 - $635,429
-62,297 Reduced 3.61%
1,664,161 $16.6 Million
Q1 2025

May 09, 2025
BUY
$5.97 - $8.15 $551,801 - $753,296
92,429 Added 5.66%
1,726,458 $10.3 Million
Q4 2024

Feb 11, 2025
SELL
$7.22 - $10.02 $164,478 - $228,265
-22,781 Reduced 1.37%
1,634,029 $12.5 Million
Q3 2024

Nov 13, 2024
SELL
$10.09 - $17.97 $3.97 Million - $7.07 Million
-393,196 Reduced 19.18%
1,656,810 $16.9 Million
Q2 2024

Aug 13, 2024
BUY
$10.33 - $18.09 $5.68 Million - $9.94 Million
549,404 Added 36.61%
2,050,006 $30.4 Million
Q1 2024

May 10, 2024
BUY
$9.89 - $13.64 $95,537 - $131,762
9,660 Added 0.65%
1,500,602 $20.5 Million
Q4 2023

Feb 14, 2024
SELL
$8.57 - $11.06 $2.77 Million - $3.57 Million
-322,817 Reduced 17.8%
1,490,942 $16.3 Million
Q3 2023

Nov 14, 2023
BUY
$10.95 - $14.6 $442,456 - $589,942
40,407 Added 2.28%
1,813,759 $19.9 Million
Q2 2023

Aug 14, 2023
BUY
$12.93 - $18.05 $4,693 - $6,552
363 Added 0.02%
1,773,352 $23.5 Million
Q1 2023

May 15, 2023
SELL
$13.02 - $22.62 $599,453 - $1.04 Million
-46,041 Reduced 2.53%
1,772,989 $24.1 Million
Q4 2022

Feb 10, 2023
BUY
$17.77 - $21.6 $1.21 Million - $1.47 Million
67,930 Added 3.88%
1,819,030 $35.5 Million
Q3 2022

Nov 14, 2022
BUY
$18.6 - $27.25 $2.26 Million - $3.31 Million
121,514 Added 7.46%
1,751,100 $33.4 Million
Q2 2022

Aug 12, 2022
BUY
$16.57 - $35.1 $2.54 Million - $5.39 Million
153,544 Added 10.4%
1,629,586 $33.6 Million
Q1 2022

May 13, 2022
BUY
$31.92 - $47.45 $13.3 Million - $19.7 Million
415,232 Added 39.14%
1,476,042 $47.5 Million
Q4 2021

Feb 14, 2022
BUY
$26.23 - $47.86 $11.6 Million - $21.1 Million
441,779 Added 71.37%
1,060,810 $49.4 Million
Q3 2021

Nov 12, 2021
BUY
$23.91 - $29.58 $2.49 Million - $3.08 Million
104,056 Added 20.21%
619,031 $16.7 Million
Q2 2021

Aug 13, 2021
BUY
$17.9 - $36.1 $9.22 Million - $18.6 Million
514,975 New
514,975 $13.2 Million

Others Institutions Holding ITOS

# of Institutions
142
Shares Held
38.2M
Call Options Held
617K
Put Options Held
471K
View Full List

About iTeos Therapeutics, Inc.

ITOS Quotes by TradingView
  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $359M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email